Abdera Therapeutics | ApexOnco - Clinical Trials news and analysis

x

“The team is super responsive to my inquiries and suggestions”

Chief Business Officer

US public biotech company

Click here for more information

Data insights

18 December 2024

Conjugates enter their first clinical trials

Two Kelun ADCs and two actinium-based radioconjugates start phase 1.

Subscribe to Abdera Therapeutics